146 related articles for article (PubMed ID: 15621160)
1. Valgancyclovir as maintenance therapy for cytomegalovirus retinitis in a lung transplant patient--a case report.
Wang TJ; Lin CP; Yang CM; Lin LL
Transplant Proc; 2004 Nov; 36(9):2826-9. PubMed ID: 15621160
[TBL] [Abstract][Full Text] [Related]
2. Treatment of bilateral cytomegalovirus retinitis with sustained-release ganciclovir implants in a child.
Malley DS; Barone R; Heinemann MH
Am J Ophthalmol; 1996 Nov; 122(5):731-2. PubMed ID: 8909217
[TBL] [Abstract][Full Text] [Related]
3. A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis.
Martin DF; Sierra-Madero J; Walmsley S; Wolitz RA; Macey K; Georgiou P; Robinson CA; Stempien MJ;
N Engl J Med; 2002 Apr; 346(15):1119-26. PubMed ID: 11948271
[TBL] [Abstract][Full Text] [Related]
4. Clinical features and outcomes of cytomegalovirus retinitis after transplantation.
Eid AJ; Bakri SJ; Kijpittayarit S; Razonable RR
Transpl Infect Dis; 2008 Feb; 10(1):13-8. PubMed ID: 17511815
[TBL] [Abstract][Full Text] [Related]
5. Cytomegalovirus retinitis after hematopoietic stem cell transplantation with alemtuzumab.
Song WK; Min YH; Kim YR; Lee SC
Ophthalmology; 2008 Oct; 115(10):1766-70. PubMed ID: 18562004
[TBL] [Abstract][Full Text] [Related]
6. Controversies in the treatment of cytomegalovirus retinitis: foscarnet versus ganciclovir.
Jabs DA
Infect Agents Dis; 1995 Sep; 4(3):131-42. PubMed ID: 8548191
[TBL] [Abstract][Full Text] [Related]
7. Treatment of cytomegalovirus retinitis with oral valganciclovir in an acquired immunodeficiency syndrome patient unresponsive to combination antiretroviral therapy.
Lee CH; Bright DC; Ferrucci S
Optometry; 2006 Apr; 77(4):167-76. PubMed ID: 16567278
[TBL] [Abstract][Full Text] [Related]
8. Rate of emergence of cytomegalovirus (CMV) mutations in leukocytes of patients with acquired immunodeficiency syndrome who are receiving valganciclovir as induction and maintenance therapy for CMV retinitis.
Boivin G; Gilbert C; Gaudreau A; Greenfield I; Sudlow R; Roberts NA
J Infect Dis; 2001 Dec; 184(12):1598-602. PubMed ID: 11740736
[TBL] [Abstract][Full Text] [Related]
9. Cytomegalovirus retinitis in AIDS patients: a comparative study of intravenous and oral ganciclovir as maintenance therapy.
Danner SA; Matheron S
AIDS; 1996 Dec; 10 Suppl 4():S7-11. PubMed ID: 9110064
[TBL] [Abstract][Full Text] [Related]
10. Valganciclovir: new preparation. CMV retinitis: a simpler, oral treatment.
Prescrire Int; 2003 Aug; 12(66):133-5. PubMed ID: 12906021
[TBL] [Abstract][Full Text] [Related]
11. Oral ganciclovir for cytomegalovirus retinitis in patients with AIDS: results of two randomized studies.
Squires KE
AIDS; 1996 Dec; 10 Suppl 4():S13-8. PubMed ID: 9110065
[TBL] [Abstract][Full Text] [Related]
12. Valganciclovir: an advance in cytomegalovirus therapeutics.
Cocohoba JM; McNicholl IR
Ann Pharmacother; 2002 Jun; 36(6):1075-9. PubMed ID: 12022911
[TBL] [Abstract][Full Text] [Related]
13. Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial. 4. Visual outcomes. Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group.
Ophthalmology; 1994 Jul; 101(7):1250-61. PubMed ID: 8035989
[TBL] [Abstract][Full Text] [Related]
14. Incremental cost-effectiveness analysis of intravenous ganciclovir versus oral ganciclovir in the maintenance treatment of newly diagnosed cytomegalovirus retinitis in patients with AIDS.
Rachlis A; Smaill F; Walker V; Hotchkies L; Jones A
Pharmacoeconomics; 1999 Jul; 16(1):71-84. PubMed ID: 10539123
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal ganciclovir maintenance injection for cytomegalovirus retinitis: efficacy of a low-volume, intermediate-dose regimen.
Teoh SC; Ou X; Lim TH
Ophthalmology; 2012 Mar; 119(3):588-95. PubMed ID: 22137552
[TBL] [Abstract][Full Text] [Related]
16. Valganciclovir: A new oral alternative for cytomegalovirus retinitis in human immunodeficiency virus-seropositive individuals.
Segarra-Newnham M; Salazar MI
Pharmacotherapy; 2002 Sep; 22(9):1124-8. PubMed ID: 12222548
[TBL] [Abstract][Full Text] [Related]
17. [Cytomegalovirus retinitis in a patient with systemic lupus erythematosus].
Furusu A; Ogino M; Yanagihara K; Yamaguchi T; Miyazaki M; Tomono K; Ozono Y; Harada T; Kohno S
Kansenshogaku Zasshi; 1997 Apr; 71(4):342-7. PubMed ID: 9164090
[TBL] [Abstract][Full Text] [Related]
18. Fundus autofluorescence changes in cytomegalovirus retinitis.
Yeh S; Forooghian F; Faia LJ; Weichel ED; Wong WT; Sen HN; Chan-Kai BT; Witherspoon SR; Lauer AK; Chew EY; Nussenblatt RB
Retina; 2010 Jan; 30(1):42-50. PubMed ID: 19996825
[TBL] [Abstract][Full Text] [Related]
19. Oral valgancyclovir versus intravenous gancyclovir for cytomegalovirus prophylaxis in kidney transplant recipients.
Said T; Nampoory MR; Pacsa AS; Essa S; Madi N; Fahim N; Abraham M; Nair P; Al-Otaibi T; Halim MA; Johny KV; Al-Mousawi M
Transplant Proc; 2007 May; 39(4):997-9. PubMed ID: 17524873
[TBL] [Abstract][Full Text] [Related]
20. Valganciclovir as treatment for cytomegalovirus disease in solid organ transplant recipients.
Len O; Gavaldà J; Aguado JM; Borrell N; Cervera C; Cisneros JM; Cuervas-Mons V; Gurguí M; Martin-Dávila P; Montejo M; Muñoz P; Bou G; Carratalà J; Torre-Cisneros J; Pahissa A;
Clin Infect Dis; 2008 Jan; 46(1):20-7. PubMed ID: 18171208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]